Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tetanus prophylaxis prescribing versus Tetanus Quick Stick immune status
NL-OMON39071Not yet recruiting
- Sponsor
- National Institute for Public Health and the Environment
- Start
- Oct 2012
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes, Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Open-label trial of Tetanus immune globulin and tetanus toxoid in Tetanus (2 arms), sponsored by National Institute for Public Health and the Environment. Primary endpoints: Immune status by Tetanus Quick Stick, Use of tetanus post-exposure prophylaxis and 3 more. Planned start Oct 2012; status: not yet recruiting.
02
Drugs
Tetanus immune globulintetanus toxoid
03
Conditions
Tetanus
Beyond the preview
Go deeper on NL-OMON39071.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON39071.